Tel Aviv, Israel

Moriya Blumkin

This inventor holds 7 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignees: Minovia Therapeutics Ltd., Tel Hashomer Medical Research Infrastructure and Services Ltd.. Active years: 2024-2026.

USPTO Granted Patents = 7 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.8

ph-index = 1


Company Filing History:


Years Active: 2024-2026

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: **Moriya Blumkin: Innovator in Mitochondrial Augmentation Therapy**

Introduction

Moriya Blumkin is a distinguished inventor based in Tel Aviv, Israel, known for his groundbreaking contributions to the field of mitochondrial augmentation therapy. With a focus on healing ocular and muscle diseases, his innovative work has the potential to transform treatment approaches in regenerative medicine.

Latest Patents

Moriya Blumkin holds two notable patents that exemplify his commitment to advancing healthcare through innovative therapies. The first patent, titled **Mitochondrial Augmentation Therapy of Ocular Diseases**, focuses on providing stem cells enriched with healthy functional mitochondria. This invention outlines pharmaceutical compositions and methods for treating ocular diseases, whether or not they're associated with acquired mitochondrial dysfunction. The second patent, **Mitochondrial Augmentation Therapy of Muscle Diseases**, offers a similar approach for muscle-related disorders, emphasizing the importance of healthy mitochondria in combating diseases, disorders, and related symptoms.

Career Highlights

Moriya is actively engaged with Minovia Therapeutics Ltd., a company dedicated to developing therapies that utilize mitochondrial augmentation to address various health conditions. His work at this innovative company places him at the forefront of research in the field, paving the way for new treatment possibilities.

Collaborations

Throughout his career, Moriya has collaborated with talented colleagues in the field, including Natalie Yivgi Ohana and Uriel Halavee. Together, they enhance the research efforts at Minovia Therapeutics Ltd., contributing to the advancement of technologies designed to improve patient outcomes.

Conclusion

Moriya Blumkin is a pioneering inventor whose work exemplifies the spirit of innovation in medicine. With significant patents that promise to revolutionize the treatment of ocular and muscle diseases, he continues to inspire the next generation of inventors and researchers. His contributions stand as a testament to the transformative power of innovation in healthcare.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…